标题
Angiogenesis in biliary tract cancer: targeting and therapeutic potential
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages -
出版商
Informa UK Limited
发表日期
2021-01-25
DOI
10.1080/13543784.2021.1881479
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
- (2020) Stephen P Hack et al. Future Oncology
- Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer
- (2020) Cindy Neuzillet et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative Ultrasound Radiomics Signatures for Noninvasive Evaluation of Biological Characteristics of Intrahepatic Cholangiocarcinoma
- (2019) Yu-ting Peng et al. ACADEMIC RADIOLOGY
- Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)
- (2018) Hendrik‐Tobias Arkenau et al. ONCOLOGIST
- Multi institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.
- (2018) Richard D. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma
- (2018) Weijing Sun et al. CANCER
- Epidermal growth factor-like domain multiple 7 (EGFL7): Expression and possible effect on biliary epithelium growth in cholangiocarcinoma
- (2018) Caterina L. Mammola et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- Radiomics: the bridge between medical imaging and personalized medicine
- (2017) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study
- (2017) Finn Ole Larsen et al. ONCOLOGY
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Pathology of intrahepatic cholangiocarcinoma
- (2017) Sandrine Vijgen et al. HEPATOBILIARY SURGERY AND NUTRITION
- Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
- (2016) Giuliana Cavalloni et al. Oncotarget
- Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
- (2016) Hong Peng et al. Oncotarget
- Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes
- (2015) Eran Sadot et al. PLoS One
- Angiopoietin-2 and Biliary Diseases: Elevated Serum, but Not Bile Levels Are Associated with Cholangiocarcinoma
- (2014) Torsten Voigtländer et al. PLoS One
- The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
- (2008) Takuya Osada et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search